Barclays’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.3K Buy
+805
New +$20.5K ﹤0.01% 4573
2025
Q4
Sell
-19,470
Closed -$499K 5425
2025
Q3
$499K Buy
+19,470
New +$494K ﹤0.01% 3811

Other funds holding IBDX

Barclays's IBDX Position: Q1 2026 in Review

Barclays opened a new position in iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q1 2026: 805 shares worth $20.3K. The stake represents ﹤0.01% of the portfolio and ranks #4573 among its holdings. This is a return to the name: Barclays previously reported a position in IBDX as recently as Q3 2025.

Barclays first reported a position in IBDX in Q3 2025 and has held it in 2 quarters since. The position peaked at $499K in Q3 2025. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • Barclays held 805 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $20.3K as of Q1 2026.
  • iShares iBonds Dec 2032 Term Corporate ETF was a new Barclays position in Q1 2026.
  • iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4573 holding.
  • Barclays first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and has held it in 2 quarters since.
  • Barclays's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $499K in Q3 2025.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.